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Objective:To determine the predictive dermoscopic fea-
tures of amelanotic and hypomelanotic melanoma.
Design:A total of 105melanomas (medianBreslow thick-
ness, 0.76mm), 170 benignmelanocytic lesions, and 222
nonmelanocytic lesions lacking significant pigment
(amelanotic, partially pigmented, and light colored) were
imaged using glass-plate dermoscopy devices and scored
for 99 dermoscopic features. Diagnostic models were de-
rived from and tested on independent randomly se-
lected lesions.
Setting: Predominantly hospital-based clinics from
5 continents.
Main OutcomeMeasures: Sensitivity, specificity, and
odds ratios for individual features andmodels for the di-
agnosis of melanoma and malignancy.
Results:Themost significant negative predictors ofmela-
noma were having multiple (3) milialike cysts (odds
ratio, 0.09; 95% confidence interval, 0.01-0.64), comma
vessels with a regular distribution (0.10; 0.01-0.70),
comma vessels as the predominant vessel type (0.16; 0.05-
0.52), symmetrical pigmentation pattern (0.18; 0.09-
0.39), irregular blue-gray globules (0.20; 0.05-0.87), and
multiple blue-gray globules (0.28; 0.10-0.81). The most
significant positive predictors were having a blue-white
veil (odds ratio,13; 95% confidence interval, 3.9-40.0),
scarlike depigmentation (4.4; 2.4-8.0), multiple blue-
gray dots (3.5; 1.9-6.4), irregularly shaped depigmenta-
tion (3.3; 2.0-5.3), irregular brown dots/globules (3.2;
1.8-5.6), 5 to 6 colors (3.2; 1.6-6.3), and predominant
central vessels (3.1; 1.6-6.0). A simplemodel distinguish-
ing melanomas from all nonmelanomas had a sensitiv-
ity of 70% and a specificity of 56% in the test set. Amodel
distinguishing all malignant lesions from benign lesions
had a sensitivity of 96% and a specificity of 37%.
Conclusion: Although the diagnostic accuracy of der-
moscopy formelanoma lacking significant pigment is in-
ferior to that of more pigmented lesions, features distin-
guishing the former frombenign lesions can be visualized
on dermoscopic evaluation.
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P URE AMELANOTIC PRIMARYmelanoma of the skin is rare,with the largest series suggest-ing an incidence of less than2% of melanomas (although
this figure is inflated because amelanotic
metastaseswere included in the study).1 Be-
cause evidence ofmelanin is usually found
in amelanotic melanoma histopathologi-
cally,2 the difficulty in diagnosing these le-
sions lieswith the clinician andnot the pa-
thologist, and a precise clinical definition
of melanoma lacking significant pigment
would be most useful. Furthermore, since
dermoscopic evaluation allows the visual-
ization of pigment not seen with the na-
ked eye, a dermoscopic definition of le-
sions lacking significant pigmentwouldbe
most useful and is presented in our study.
Although dermoscopic evaluation has
been shown to improve the accuracy of
pigmented melanoma diagnosis com-
pared with naked eye examination,3 less
literature is found regarding melanomas
lacking significant pigment.4-8 Still, der-
moscopic evaluation has been shown to
be superior to naked eye examination for
the diagnosis of amelanotic or hypomela-
notic melanoma.4 To assess the diagnos-
CME available online at
www.jamaarchivescme.com
For editorial comment
see page 1207
Author Affiliations are listed at
the end of this article.
(REPRINTED) ARCH DERMATOL/VOL 144 (NO. 9), SEP 2008 WWW.ARCHDERMATOL.COM
1120
©2008 American Medical Association. All rights reserved.
Downloaded From: http://archderm.jamanetwork.com/ by a UQ Library User  on 11/12/2015
tic significance of dermoscopic features in these lesions,
a large series of melanomas as well as nonmelanocytic
and benign melanocytic lesions lacking significant pig-
ment was examined.
METHODS
INCLUSION AND EXCLUSION CRITERIA
We selected 3 morphological dermoscopic variants of lesions
lacking significant pigment. The first type, amelanotic lesions,
have nomelanin pigmentation (ie, tan, dark brown, blue, gray,
or black) upon dermoscopic inspection. Tan pigmentation is
defined as light brown pigmentation that is darker than the sur-
rounding skin. In addition, 2 subgroups of hypomelanotic le-
sions were defined. On dermoscopic evaluation, partially pig-
mented lesions have a melanin pigmentation area of less than
25% of the total surface area. Light-colored (slightly pig-
mented) lesions have only tan, light blue, or light gray pig-
mentation that may occupy more than 25% of the total surface
area; no dark brown, deep blue, or black pigmentation is found.
Lesions were excluded because of poor image quality or be-
cause they did not fit within any of the defined pigmentation
categories. All lesion images used in the study were taken ret-
rospectively from photographic libraries at various institu-
tions, and patients gave verbal or written consent for their use.
IMAGE ACQUISITION
Digital dermoscopic images taken with glass plate/liquid pho-
tographic devices were obtained from members of the Interna-
tionalDermoscopySociety from5continents.A requestwasmade
for images of all melanomas satisfying the inclusion criteria, and
a random selection of melanocytic and nonmelanocytic lesions
also lacking significantpigmentwasmade (nonmelanoma tomela-
noma ratio, 3:1). For all lesions, the diagnosis was histopatho-
logically confirmed, except for somenevi that showedno changes
following consecutive digitalmonitoring. To assess adequate im-
age quality and assign the pigmentation category, lesions were
examined by one of us (S.W.M.) blinded to the diagnosis or re-
ferring center. All images were adjusted to 10 magnification
to approximate handheld dermoscopy devices. A total of 497 le-
sions, including 105melanomas (medianBreslow thickness, 0.76
mm), were included in the study. Table 1 shows the fre-
quencyof lesionswithin eachpigmentation category andTable2,
the frequency of lesion diagnoses.
DERMOSCOPIC FEATURES
The features included in the study were determined by con-
sensus of the members of the International Dermoscopy Soci-
ety. These features were either based on the existing literature
or on clinicians’ anecdotal experience. Before scoring, clini-
cians were given a morphological tutorial to define all vascu-
lar and newly described features. This tutorial is available at
the International Desmoscopy Society Web site: http://
dermoscopy-ids.org/studies (click on “Amelanotic melanoma
study”). Twelve clinicians (J.K., M.A.P., A.M., R.B., J.M., S.P.,
G.A., I.Z., H.S.R., M.O., H.C., and V.A.-S.) blinded to the le-
sion diagnoses and experienced in dermoscopic evaluation
scored 99 individual morphological features in approximately
equal sample sizes. All clinicians scored 55 preselected lesions
with a variety of vascular features to assess interobserver con-
cordance for vascular structures. One feature, light brown struc-
tureless areas, was chosen after scoring was completed andwas
subsequently scored by one of us (S.W.M.). The eTable (http:
//www.archdermatol.com) includes the 99 criteriawith 21 items
identified in the disease-specific groups for melanocytic, seb-
orrheic keratosis, BCC (basal cell carcinoma), and vascular cri-
teria. Precise morphological definitions of these features can
be found elsewhere.9-15
First-step dermoscopic analysis to define a melanocytic
lesion16 occurred if 1 or more of pigment network/pseudo-
network, aggregated globules (not multiple blue-gray glob-
ules), streaks (pseudopods/radial streaming), homogeneous blue
pigmentation, or a parallel pattern (on volar sites) were pres-
ent. If these were absent and the lesion lacked features of seb-
orrheic keratosis (3milialike cysts, comedolike openings [ir-
Table 1. Lesion Pigmentation Categoriesa
Lesion
Pigmentation Melanoma
Benign
Melanocytic Nonmelanocytic
Amelanotic 15 36 80
Partially pigmented 51 (16)b 40 (16)b 92 (36)b
Light colored 55 (16)b 110 (16)b 86 (36)b
Total 105 170 222
aA total of 497 lesions met morphological and pigmentation criteria (see
the “Methods” section for a list of inclusion criteria).
bNumber in parentheses indicates lesions that had both partially
pigmented and light-colored characteristics.
Table 2. Diagnosis Frequency
Diagnosis No. of Lesions
Melanoma
Totala 105
Superficial spreading 80
Nodular 7
Lentigo maligna 3
In situ arising within nevus 13
Acral invasive 1
Acral in situ 1
Benign melanocytic
Total 170
Ephelisb 1
Lentigob 2
Nevus
Uncertain classification 14
Junctional/compound 27
Dermal 47
Spitz 11
Clark/dysplastic 25
Monitored unchanged 43
Nonmelanocytic
Total 222
Basal cell carcinoma 126
Dermatofibroma 17
Hemangioma 8
Seborrheic keratosis 22
Lichen planuslike keratosis 2
Actinic keratosis 8
Bowen disease 7
Squamous cell carcinoma 4
Keratoacanthoma 1
Other 27
aThe median Breslow thickness for all melanomas was 0.76 mm (range,
0-8 mm) and for invasive melanomas was 1.00 mm (range, 0.19-8 mm).
bEphelis and lentigo are not melanocytic lesions, but they are included in
this category because they mimic melanocytic lesions on dermoscopic
examination.
(REPRINTED) ARCH DERMATOL/VOL 144 (NO. 9), SEP 2008 WWW.ARCHDERMATOL.COM
1121
©2008 American Medical Association. All rights reserved.
Downloaded From: http://archderm.jamanetwork.com/ by a UQ Library User  on 11/12/2015
regular crypts], light brown fingerprintlike areas, or fissures/
ridges), BCC (arborizing vessels, leaflike areas, large blue-
gray ovoid nests,multiple blue-gray globules, spokewheel areas,
or ulceration), vascular lesions (red-blue lacunes or red-blue
to red-black homogeneous areas), or dermatofibroma (central
white patch), then the lesion was also classified by default as
melanocytic. Second-step analysis used the feature-basedMen-
zies method, 7-point checklist, and 3-point checklist, as de-
scribed elsewhere.17-19 The ABCDmethod of Stolz et al was not
included because it is not, in general, a feature-based system.11
STATISTICAL ANALYSIS
SPSS statistical software, version 14 (SPSS Inc, Chicago, Illi-
nois), was used to analyze the data. Two-tailed tests with a sig-
nificance level of 5%were used throughout. To develop and test
the performance of potential predictive scores based on mor-
phological features, a random sample of 80% of lesions was as-
signed to a training set and the remaining 20% to a test set. Ini-
tially, all featureswere entered as candidate variables in amultiple
logistic regression analysis with backward stepwise variable se-
lection to identify the independent predictors of melanoma in
the training set. The resulting best-fitting model involved a lin-
ear predictor, which included 18 features, far toomany for prac-
tical implementation in a clinical setting.One of us (S.W.M.) had
previously developed clinically useful scores for diagnosingmela-
nomaandpigmentedBCCbyconsidering featureswithhigh speci-
ficity and low sensitivity.17,20 The possible positive features for
diagnosing melanoma lacking significant pigment in the train-
ing set were therefore restricted to those with high specificity
(80%) forwhich distribution differed significantly between the
melanoma group and each of the nonmelanocytic and benign
melanocytic groups. In addition, low sensitivity features (1%)
for melanoma were included for model development. Using all
features as candidate variables,multiple logistic regression analy-
sis with backward stepwise variable selection was also used to
identify the independent predictors of malignant lesions from
benign lesions in the training set.
The area under the receiver operating characteristic curve
and its standard error were used to quantify the global dis-
criminatory power of a potential diagnostic score and to assist
in determining a suitable cutoff point on the basis of perfor-
mance in the training set. The sensitivity and specificity of the
resulting classifications were then assessed in the indepen-
dent test set.
RESULTS
INTEROBSERVER AGREEMENT
Interobserver concordance about the 9main vascular fea-
tures, expressed as the median percentage of clinicians
who agreed with the presence or absence of the feature
per lesion, was assessed for 55 preselected lesions that
exhibited a variety of vascular structures. Agreement was
high for arborizing vessels (median, 100%; interquartile
range, 91%-100%), comma vessels (82%; 73%-91%), dot-
ted vessels (82%; 73%-100%), hairpin vessels (91%; 82%-
100%), vesselswithwhite or yellowpigmented halo (91%;
82%-100%),milky red/pink areas (82%; 64%-91%),milky
red globules (91%; 73%-100%), and nontumor vessels
(91%; 82%-100%). In contrast, linear irregular vessels had
amedian agreement per lesion of 73% (interquartile range,
64%-91%), and only 42% (95% confidence interval, 30%-
55%) of lesions showed more than 80% agreement for
the presence or absence of linear irregular vessels.
TWO-STEP DERMOSCOPIC ANALYSIS
The standard first-step procedure,16 which describes the
dermoscopic features distinguishing melanocytic from
nonmelanocytic lesions, was applied to themelanoma set.
However, only 75 of 105 melanomas lacking significant
pigment (71.4%) were correctly classified as melano-
cytic using this method. Furthermore, the 3 second-
step methods for distinguishing benign melanocytic le-
sions from melanoma showed poor sensitivity (range,
41%-54%) (Table 3).
DERMOSCOPIC FEATURES OF MELANOMAS
VS NONMELANOMAS
Based on our aforementioned analysis, current dermo-
scopic algorithms developed using more heavily pig-
mented lesions were not reliable for correctly classify-
ing a melanoma lacking significant pigment. Therefore,
an analysis of the sensitivity and specificity of features
for the diagnosis of melanoma compared with all non-
melanomas was performed (Table 4).
The most significant negative predictors of mela-
noma, in order of lowest odds ratio for melanoma, were
havingmultiple (3)milialike cysts (Figure1), comma
vessels as the predominant vessel type (Figure 1), sym-
metrical pigmentationpattern, blue-gray globules thatwere
irregular in size and/ordistribution,multipleblue-grayglob-
ules, arborizing small diameter vessels, and symmetrical
shape. Of these features, only symmetrical pigmentation
pattern and symmetrical lesion shapewere significant nega-
tive predictors formelanoma compared with themelano-
cytic andnonmelanocytic nonmelanoma lesions. Thepres-
ence of multiple milialike cysts, regularly distributed
comma vessels, and comma vessels as the most predomi-
nant vessel type did not differ significantly in frequency
betweenmelanoma and nonmelanocytic lesions, whereas
the presence of blue-gray globules (present or irregular),
small diameter arborizing vessels, and arborizing vessels
Table 3. Second-Step Methods for the Diagnosis of Melanoma
Specificity, %
Method Sensitivity, % All Nonmelanoma Melanocytic Lesions Nonmelanocytic Lesions
Menzies et al17 54 76 71 79
7-Point checklist18 41 83 78 87
3-Point checklist19 50 71 71 71
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as the predominant vessel type did not differ significantly
in frequency betweenmelanoma and benignmelanocytic
lesions (data not shown).
Themost positive predictors ofmelanomawere, in or-
der, having a blue-white veil, scarlike depigmentation,
multiple blue-gray dots, irregularly shaped depigmenta-
tion, brown dots or globules irregular in size or distri-
bution, 5 to 6 colors, predominant central vessels, red-
blue color, and peripheral light brown structureless areas
of more than 10% of the area of the lesion. All these fea-
tures were significant positive predictors of melanoma
compared with benign melanocytic lesions and nonme-
lanocytic lesions.
Of vascular or vascular-related features, themost pre-
dictive for melanoma were, in order, having predomi-
nantly central vessels, hairpin vessels, milky red-pink
areas, more than 1 shade of pink, a combination of dot-
ted and linear irregular vessels, and linear irregular ves-
sels as the predominant vessel type. With the exception
of hairpin vessels, for which the distribution did not dif-
fer significantly between melanoma and nonmelano-
cytic lesions (data not shown), all these vascular-related
structures were significant positive predictors of mela-
noma comparedwith benignmelanocytic lesions andnon-
melanocytic lesions.
The distribution of the number of vessel types per
lesion (0, 1, or2) differed significantly between mela-
noma and nonmelanoma lesions (Table 5). A higher
percentage of lesions with 2 or more vessels (ie, poly-
morphous vessels) was seen among melanomas than
nonmelanomas. The odds ratio for melanoma was 2.1
(95% confidence interval, 1.02-4.2) for lesions with2
vessels compared with those with no vessels; 11% of
melanomas had no visible vessels.
Table 4. Univariate Analysis of Melanomas vs All Nonmelanomasa
Feature Sensitivity, %b Specificity, %c
Odds Ratio
(95% Confidence Interval) P Valued
Negative
Multiple (3) milialike cysts 1.0 90.1 0.087 (0.012-0.64) .003
Comma vessels, regular distribution 1.0 90.8 0.10 (0.01-0.70) .004
Comma vessels as the predominant vessel type 2.9 84.4 0.16 (0.05-0.52) .001
Symmetrical pigmentation pattern 7.6 68.9 0.18 (0.09-0.39) .001
Blue-gray globules of irregular size and/or distribution 1.9 91.3 0.20 (0.05-0.87) .02
Multiple blue-gray globules 3.8 87.8 0.28 (0.10-0.81) .01
Arborizing small diameter vessels 6.7 81.4 0.31 (0.14-0.70) .003
Symmetrical shape 23.8 52.0 0.34 (0.21-0.55) .001
Arborizing vessels as the predominant vessel type 8.6 82.4 0.44 (0.21-0.91) .02
Positive
Blue-white veil 11.4 99.0 13.0 (3.9-40.0) .001e
Scarlike depigmentation 22.9 93.6 4.4 (2.4-8.0) .001
Multiple blue-gray dots (peppering) 21.9 92.6 3.5 (1.9-6.4) .001
Irregularly shaped depigmentation 35.2 85.7 3.3 (2.0-5.3) .001
Irregular brown dots/globules 23.8 91.1 3.2 (1.8-5.6) .001
5-6 Colors 15.2 94.6 3.2 (1.6-6.3) .001
Predominant central vessels 16.2 94.1 3.1 (1.6-6.0) .001
Red-blue color 27.6 88.3 2.9 (1.7-4.9) .001
Peripheral light brown structureless areas 10% 19.0 92.6 2.9 (1.6-5.5) .001
Blue color 19.0 92.3 2.8 (1.5-5.2) .001
Asymmetrical pigmentation pattern 75.2 46.2 2.6 (1.6-4.2) .001
Hairpin vessels 21.0 90.6 2.5 (1.4-4.5) .001
Milky red pink areas 50.5 71.2 2.5 (1.6-3.9) .001
1 Shade of pink 32.4 82.9 2.3 (1.4-3.8) .001
Asymmetrical shape 57.1 63.3 2.3 (1.5-3.5) .001
Dotted and linear irregular vessels 29.5 84.7 2.3 (1.4-3.8) .001
Linear irregular vessels as predominant vessel type 34.3 79.8 2.1 (1.3-3.3) .002
Multifocal depigmentation 27.6 84.4 2.1 (1.2-3.4) .004
Atypical network 21.0 88.5 2.0 (1.2-3.6) .01
Vessels of irregular shape/size 62.9 53.8 2.0 (1.3-3.1) .002
Milky red globules 21.0 88.3 2.0 (1.1-3.5) .02
Dotted vessels as predominant vessel type 33.3 79.8 2.0 (1.2-3.2) .004
Dots/globules of irregular size or distribution 22.9 86.5 1.9 (1.1-3.3) .02
1 Shade of tan/brown 42.9 71.9 1.9 (1.2-3.0) .004
Streaks (pseudopods/radial streaming) 4.8 98.7 3.9 (1.1-14.0) .04d
Central white striated patch 4.8 98.7 3.9 (1.1-14.0) .04d
Gray color 33.3 77.0 1.7 (1.1-2.7) .03
Linear irregular vessels 40.0 70.9 1.6 (1.0-2.5) .03
aThose features in bold type are significant with the same odds ratio trend in both melanocytic and nonmelanocytic lesions compared with melanoma.
bThe percentage of melanomas with that feature.
cThe percentage of nonmelanomas without that feature.
dPearson 2 test (.05 indicates significance) unless otherwise indicated.
eFisher exact test.
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DERMOSCOPIC FEATURES
OF THIN VS THICK MELANOMA
Comparison of thin (0.75mm) vs thick (1mm)mela-
nomas showed that thinmelanomas had an increased fre-
quencyof atypical network, network/pseudonetwork,more
than 1 shade of tan or brown, graduated edge throughout
the entire lesion, and dotted/pinpoint vessels as the pre-
dominant type. In contrast, thickmelanomas had a greater
frequency of hairpin vessels, peripheral vessels, large blue-
gray ovoid nests, central vessels, ulceration, large diam-
eter vessels, and pink color (Table 6).
MODEL DISTINGUISHING MELANOMA
FROM NONMELANOMA
The multiple logistic regression analysis, which used as
candidate variables those with high specificity (80%)
or very low sensitivity (1%) for melanoma and whose
distribution for the high specificity variables differed sig-
nificantly between the melanoma group and each of the
nonmelanocytic and benign melanocytic groups, iden-
tified 8 independent predictors of melanoma in the train-
ing set. A simple model suitable for distinguishingmela-
noma from all nonmelanoma (includingmalignant BCC,
Bowen disease, and squamous cell carcinoma) was de-
veloped using these 8 features (Table 7). Here, a diag-
nosis of melanoma is made if the lesion does not have
the negative feature of multiple (3) milialike cysts and
has 1 or more of 7 positive features. In the training set,
the sensitivity was 75% and specificity 66% for the di-
agnosis ofmelanoma. In the independent test set, the sen-
sitivity was 70% and specificity 56%. Figure 2 shows
an example of a lesion evaluated using the model.
MODEL DISTINGUISHING ALL MALIGNANT
FROM BENIGN LESIONS
Because the first model lacked high sensitivity for the di-
agnosis of melanoma, another model was developed to
distinguish all malignant lesions (melanoma, BCC, Bo-
wen disease, squamous cell carcinoma, and keratoacan-
thoma) from nonmalignant lesions. A clinically practi-
cal model suitable for distinguishing malignant from
benign lesions was developed using the 12 independent
predictor features (Table 8). For a lesion to be diag-
Figure 1. This lesion has 2 negative predictors of melanoma: regularly
distributed comma vessels (arrows) (odds ratio, 0.10), which are often, as in
this case, found predominantly at the periphery of the lesion, and comma
vessels as the predominant vessel type (odds ratio, 0.16). The diagnosis was
dermal nevus.
Table 5. Significance of Polymorphous Vessels
No. of
Vesselsa
No. (%) of Lesions
Melanoma Nonmelanoma
0 11 (11) 65 (17)
1 33 (31) 153 (39)
2b 61 (58) 174 (44)
aVessel types included arborizing, linear irregular, comma, hairpin, dotted,
glomerular, and milky red globules.
bThere was a significant increase in the number of polymorphous vessels
(2) in melanomas vs nonmelanomas (2 test; P = .04).
Table 6. Dermoscopic Features Distinguishing Thick
vs Thin Melanomas
Dermoscopic Feature
Lesion
Thickness,a mm
P
Valueb
0.75
(n=44)
1
(n=32)
Hairpin vessels 3 (6.8) 13 (40.6)  .001
Atypical network 17 (38.6) 2 (6.3) .001
Pigment network/pseudonetwork 20 (45.5) 4 (12.5) .002
Peripheral vessels (at or near edge) 13 (29.5) 20 (62.5) .004
Large blue-gray ovoid nests 0 5 (15.6) .01c
Central vessels 11 (25) 17 (53.1) .01
Ulceration 2 (4.5) 8 (25.0) .01c
1 Shade of tan/brown 25 (56.8) 10 (31.3) .03
Large diameter vessels 6 (13.6) 11 (34.4) .03
Graduated edge (entire lesion) 30 (68.2) 14 (43.8) .03
Pink color 24 (54.5) 25 (78.1) .03
Dotted/pinpoint as predominant
vessel type
18 (40.9) 6 (18.8) .04
aData are given as the number (percentage) of lesions.
bPearson 2 test (.05 indicates significance) unless otherwise indicated.
cFisher exact test.
Table 7. Simple Dermoscopic Model for the Diagnosis
of Melanoma Lacking Significant Pigmenta
Negative feature (if present, nonmelanoma)
3 Milialike cysts
Positive features (if any 1 present, then melanoma)
Irregularly sized or distributed brown dots/globules
Multiple blue/gray dots
Irregularly shaped depigmentation
Blue-white veil
1 Shade of pink
Predominant central vessels
Dotted and linear irregular vessels
a In the training set, sensitivity was 75% and specificity was 66% for the
diagnosis of melanoma (area under the receiver operating characteristic
curve, 0.74; SE, 0.03). In the independent test set, sensitivity was 70% and
specificity was 56% (area under the receiver operating characteristic curve,
0.69; SE, 0.07).
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nosed as malignant using this model, the total number
of positive features must equal or exceed the total num-
ber of negative features. In the independent test set, the
sensitivity for the diagnosis of malignancywas 96% (95%
formelanoma) and the specificity, 37%. To improve speci-
ficity, the cutoff point for the score can be increased.How-
ever, a significant reduction in sensitivity will result
(Table 8). Figure 3 shows an example of a lesion evalu-
ated using the model.
COMMENT
Although dermoscopic evaluation has been shown to im-
prove the diagnosis of melanoma lacking significant pig-
ment, it is clear from these results that diagnostic accu-
racy is significantly diminished compared with
significantly pigmented lesions. Whereas many dermo-
scopic methods achieve a sensitivity exceeding 90% and
specificity exceeding 70% with predominantly pig-
mented lesions,16 the model described in our study of le-
sions lacking significant pigment had a sensitivity of 75%
and specificity of 66% for melanoma. Although the sen-
sitivity for melanoma could be increased to more than
90% when classifying all malignant vs nonmalignant le-
sions, this was at the expense of a very low specificity
(37%). Furthermore, the first-step procedure devel-
oped primarily for pigmented lesions to distinguish me-
lanocytic lesions frompigmented BCC, hemangioma, seb-
orrheic keratoses, and dermatofibroma and standard
second-step procedures to distinguish melanomas from
benign melanocytic lesions were not effective discrimi-
nators for lesions lacking significant pigment.
Loss of pigmentation in lesions included in this study
could be owing to either a true lack of significant mela-
nin in tumor cells or to regression. Because of variation
in reporting regression among different clinics, we could
not stratify results based on the 2 different histopatho-
logical entities: regression vs amelanosis. It is noted that
the dermoscopic features of scarlike depigmentation and
multiple blue-gray dots (melanophages) were found in
23% and 22% of our melanomas, respectively, indicat-
ing regression in these lesions. It is probable that cer-
tain dermoscopic features are preferentially found inmela-
nomas displaying true amelanosis vs regression.
The importance of vascular structures for the diag-
nosis of lesions lacking pigment is clear from this study.
Two of 8 features described in the model distinguishing
melanomas from nonmelanomas and 3 of 11 features in
Figure 2. This light-colored lesion illustrates the positive dermoscopic
features in the model distinguishing melanoma from nonmelanoma
(Table 7): having predominant central vessels, more than 1 shade of pink,
dotted (arrows) and linear (arrowhead) irregular vessels, and irregularly
shaped depigmentation (asterisk). The diagnosis was in situ melanoma
arising in a dysplastic nevus.
Table 8. Dermoscopic Model for Distinguishing Malignant
From Nonmalignant Lesions Lacking Significant Pigmenta
Negative features (score –1 for each feature)
Multiple (3) milialike cysts
Symmetrical pigmentation pattern
Comma vessels in regular distribution
Multiple brown dots
Positive features (score 1 for each feature)
Depigmentation
Small diameter arborizing vessels
Leaflike areas
Ulceration
Irregular size or distributed blue-gray globules
Gray color
Large-diameter vessels
a In this model, the area under the receiver operating characteristic (ROC)
curve was 0.85 (SE, 0.02) for the training set and 0.79 (SE, 0.04) in the test
set. Two thresholds for malignant neoplasm can be used, depending on the
preferred sensitivity and specificity results:
High sensitivity model: A nonnegative total score (0) is necessary for a
diagnosis of malignant neoplasm. In the training set, sensitivity was 97%
and specificity was 41% for the diagnosis of malignant neoplasm; sensitivity
for the diagnosis of melanoma was 98%. In the independent test set,
sensitivity for the diagnosis of malignant neoplasm was 96% and the
specificity, 37%; sensitivity for the diagnosis of melanoma was 95%.
Higher specificity model: A positive total score (1) is necessary for a
diagnosis of malignant neoplasm. In the training set, sensitivity was 77%
and specificity was 79% for the diagnosis of malignant neoplasm; sensitivity
for the diagnosis of melanoma was 69%. In the independent test set,
sensitivity for the diagnosis of malignant neoplasm was 79% and the
specificity, 65%; sensitivity for the diagnosis of melanoma was 80%.
Figure 3. This 65-mm raised yellow lesion has small-diameter arborizing
(thick arrows) and linear irregular vessels (thin arrows). Using the model
distinguishing all malignant from all benign lesions (Table 8), a score of 1
indicates the need for excision or biopsy. Diagnosis is melanoma, 0.8 mm,
Clark level 4.
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the model distinguishing malignant from benign le-
sionswere vascular structures. Furthermore, of the 7most
significant variables indicative of melanoma or nonmela-
noma in a univariate analysis (all with an odds ratio ex-
ceeding 4 for the diagnosis of melanoma or nonmela-
noma), 2 were vascular structures (ie, comma vessels
regularly distributed and comma vessels as the predomi-
nant vessel type). Nevertheless, vascular structures failed
to reach the level of significant positive predictors ofmela-
noma compared with other classically described nonva-
scular structures. In this regard, the only vascular struc-
ture exceeding an odds ratio of 3 for melanoma, when
distinguishing melanomas from all nonmelanomas, was
the feature of predominant central vessels. Most other
vascular structures positively predicting melanoma had
odds ratios ranging from 2 to 2.5.
Vascular structures previously reported to be signifi-
cant features of melanoma were confirmed by the re-
sults of our larger series. In 2 previous series,4,21 linear
irregular vessels have been found to be an important vas-
cular predictor ofmelanoma. However, in our study, they
were not significantly different in melanomas vs benign
melanocytic lesions. In our series, amore significant find-
ing was having linear irregular vessels as the predomi-
nant vessel type. This was significantly different inmela-
nomas compared with benign melanocytic and
nonmelanocytic lesions, with a sensitivity of 34% and
specificity of 80% formelanoma overall (odds ratio, 2.1).
However, as noted by Pizzichetta et al,4 the combina-
tion of linear irregular and dotted vessels was diagnos-
tically more important and was significantly different
among benign melanocytic and nonmelanocytic lesions
compared with melanomas, with a 30% sensitivity and
85% specificity overall (odds ratio, 2.3 for melanoma).
Milky red globules and areas4,21,22 were also con-
firmed to be predictors ofmelanoma in our study. Dotted/
pinpoint vessels, indicative of melanocytic tumors rather
thanmelanoma,21 were not significantly different among
the melanoma vs the benign melanocytic lesion group.
The rarity of comma vessels in melanomas seen in our
series is consistent with observations made by others; in
previous reports, none of 150 predominantly pig-
mented melanomas21 and none of 44 amelanotic/
hypomelanotic melanomas had these vessels.4 Comma
vessels are found in 66% of dermal or congenital nevi,
with a very high positive predictive value of 94% for
comma vessels in these lesions, as previously re-
ported.21 Finally, the absence of multiple gray-blue glob-
ules in pigmented melanomas21 and amelanotic/
hypomelanoticmelanomas,4 in contrast to their presence
in pigmented BCC, was reconfirmed in our study.
Although a large series of nonmelanoma lesions was
included in this study,nopyogenic granulomaswere found.
Recently, the dermoscopic features of a series of these le-
sions have been reported, and common features include
reddish homogeneous areas, white collarette, “white rail”
lines that intersect the lesion, and ulceration.23
This study was morphologically based. It did not in-
clude clinical information, such as age, sex, location, ugly
duckling sign, and evolution, in formulating the diagnos-
ticmethods. However, such informationmay improve di-
agnostic accuracy for these lesions in clinical practice.
In addition, our study included selection biases. Le-
sions were recruited from multiple centers retrospec-
tively and, in many cases, may not have been from con-
secutive patients at each institution. More important,
because the study was not prospective, hypomelanotic
lesions that were not photographed, leading to missing
data, may suggest a morphological bias in our collec-
tion of cases. Furthermore, the skin phototype was not
recorded for lesions, which may influence dermoscopic
features such as the type and quantity of blood vessels.
Finally, it is important to realize that this study con-
sisted of glass plate dermoscopic images at a magnifica-
tion consistent with 10 handheld dermoscopes. Al-
though compression of vessels may be reduced by
application of ultrasonography gel, there was no doubt
that significant compression occurred withmany lesions
imaged. Indeed, this is the reality with such devices in
the clinical setting. Many of the vascular-related fea-
tures scored in this study would have varied depending
on the pressure applied to the skin. In this regard, our
study showed that 11%ofmelanomas had no visible ves-
sels. This is consistent with the previous report of 9% in
amelanotic/hypomelanotic melanoma in a study by Piz-
zichetta et al.4 More significant vascular detail may be
found using cross-polarized noncontact dermoscopy de-
vices24 or by increasing magnification. Future planned
studies will help determinewhether such devices will al-
low description of greater discriminating features ofma-
lignancy in lesions lacking significant pigment.
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WEB-ONLY CONTENT
eTable. Scored Dermoscopy Features
Melanocytic criteria
Pigment network/pseudonetwork
Aggregated globules (not multiple blue-gray globules)
Streaks (pseudopods/radial streaming)
Homogeneous blue pigmentation
Parallel pattern (on volar sites)
Seborrheic keratosis criteria
Multiple (3) milialike cysts
1-3 Milialike cysts
Comedolike openings (irregular crypts)
Light brown fingerprintlike areas
Fissures/ridges
Basal cell carcinoma criteria
Arborizing vessels
Arborizing small diameter
Arborizing large diameter
Leaflike areas
Large blue-gray ovoid nests
Multiple blue-gray globules
Spoke wheel areas
Ulceration
Vascular lesion criteria
Red-blue lacunes
Red-blue to red-black homogeneous areas
Vessels of the dermal plexus
Other criteria
Central white striated patch
Typical network (regular prominent or discrete)
Atypical network (broadened and irregular, includes rhomboidal structures
on face)
Negative pigment network
Regular dots/globules (regular size and distribution)
Irregular dots/globules (irregular size and/or distribution)
Regular black dots/globules
Irregular black dots/globules
Peripheral black dots/globules
Central black dots/globules
Regular brown dots/globules
Irregular brown dots/globules
Multiple brown dots
Regular blue-gray globules
Irregular blue-gray globules
Multiple blue-gray dots (peppering)
Irregular-shaped depigmentation
Regular depigmentation (symmetrical distribution)
Single focus depigmentation
Multifocal depigmentation
Diffuse depigmentation (throughout the lesion)
Scarlike depigmentation
Blue-white veil
Tan
1 Shade of tan/brown
Dark brown
Red-blue
Blue
Gray
Pink
(continued)
eTable. Scored Dermoscopy Features (cont)
1 Shade of pink
Black
White
Color count 1-6 (tan, dark brown, red, blue, gray, or black; excluding white)
Sharply demarcated colors
Blurred “out of focus” colors
Follicular plugs
Abrupt edge (any aspect)
Graduated edge (entire lesion)
Symmetrical pigmentation pattern
Asymmetrical pigmentation pattern
Symmetrical shape
Asymmetrical shape
Irregular blotch (irregular-shaped homogeneous area larger than 10% of
the area)
Regular blotch
Regular vessels (uniform shape/size)
Irregular vessels (irregular shape/size)
Peripheral vessels (at or near the edge)
Central vessels
Predominantly peripheral vessels (all vessel types combined)
Predominantly central vessels (all vessel types combined)
Large-diameter vessels
Linear-irregular or dotted vessels not clearly combined with regression
structures
Comma vessels of regular distribution
Comma vessels of irregular distribution
Hairpin vessels
Peripheral hairpin vessels
Central hairpin vessels
Regular distribution of dotted/pinpoint vessels (not confined to the holes
of pigment network)
Irregular distribution of dotted/pinpoint vessels (not confined to the holes
of pigment network)
Linear irregular vessels
Dotted and linear irregular vessels
Radial (wreathlike or “crown”) vessels
Milky red-pink areas
Glomerular vessels
Milky red globules
Some vessels surrounded by white halo or yellow pigment
Most vessels surrounded by white halo or yellow pigment
Predominant vessel type (circle one only):
Arborizing
Comma
Crown/radial
Dotted/pinpoint vessels (not confined to the holes of the pigment network)
Hairpin
Linear irregular
Vessels with white or yellow pigmented halo
Glomerular
Other features _____________________
Light brown peripheral structureless areas occupy10% of the lesion.
The morphological definitions are as described elsewhere (see references 9-15
in the published article). Examples of vascular and other definitions are found
at the International Dermoscopy Society Web site: http://dermoscopy-ids.org
/studies (click on “Amelanotic melanoma study”).
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